# Drug-Drug Interaction Study Between CJ-12420 and Clarithromycin in Healthy Male Subjects

> **NCT02052336** · PHASE1 · COMPLETED · sponsor: **HK inno.N Corporation** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** CJ-12420 200mg + Clarithromycin 500mg
- **DRUG:** CJ-12420 200mg
- **DRUG:** Clarithromycin 500mg

## Key facts

- **NCT ID:** NCT02052336
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-01
- **Final completion:** 2014-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02052336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02052336, "Drug-Drug Interaction Study Between CJ-12420 and Clarithromycin in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02052336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*